Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Halberd Corp
HALB
Healthcare
Biotechnology
Halberd Corporation is a holding company. The Company is engaged in the acquisition vehicle for established businesses. It is also developing treatments for neurodegenerative diseases, such as post-traumatic stress disorder/chronic traumatic encephalopathy (PTSD/ CTE), Alzheimer’s disease and Parkinson’s disease. It has two issued patents, and four provisional patent applications related to the...
extracorporeal treatment of blood-borne diseases and cerebrospinal fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other viruses. Its Sequential Dialysis Technique is a methodology that physically removes the pathophysiologic basis of the disease, eliminating it without side effects. The Company’s subsidiaries include Alaric Corporation, and Extendalife, Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCPK:HALB)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
Next
(10)
•••
AveragePenny
X
Post by
AveragePenny
on Aug 26, 2024 8:33am
Halberd Corp. Issues Letter to Shareholders
JACKSON CENTER, Pa., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC PINK: HALB) today issued the following letter to it shareholders: Halberd Corp. - Taking a Moment to Recenter Our
...more
(10)
•••
AveragePenny
X
Post by
AveragePenny
on Jul 24, 2024 8:21am
Halberd Corp’s (OTC: HALB) Groundbreaking Traumatic Brain...
JACKSON CENTER, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC-PINK: "HALB”) has announced encouraging preliminary outcomes from its Phase II testing at Mississippi State
...more
(10)
•••
AveragePenny
X
Post by
AveragePenny
on May 22, 2024 8:44am
Halberd/Athena GTX Research Promises a Much Brighter Future
Walt Disney once said, "All our dreams can come true if we have the courage to pursue them". JACKSON CENTER, PA / ACCESSWIRE / May 22, 2024 / Halberd Corporation (OTC PINK:HALB)&
...more
(10)
•••
AveragePenny
X
Post by
AveragePenny
on May 09, 2024 8:36am
Halberd's Traumatic Brain Injury Treatment Projects Align
Daniel J. Harvey and Adam Lambert Improving Servicemember Transition to Reduce Veteran Suicide Act, passed the U.S. House unanimously. JACKSON CENTER, PA / ACCESSWIRE / May 9, 2024 / Halberd
...more
(10)
•••
AveragePenny
X
Post by
AveragePenny
on Apr 30, 2024 8:34am
Halberd's Patented LDN+ Drug Has Begun Pre-Pilot Trials With
News Link: https://www.accesswire.com/857948/halberds-patented-ldn-drug-has-begun-pre-pilot-trials-with-military-veterans JACKSON CENTER, PA / ACCESSWIRE / April 30, 2024 / Halberd
...more
(10)
•••
AveragePenny
X
Post by
AveragePenny
on Apr 04, 2024 9:43am
Halberd's Patented Drug, LDN+, the Subject of a Limited ...
JACKSON CENTER, PA / ACCESSWIRE / April 4, 2024 / Halberd Corporation's (OTC PINK:HALB) Patented LDN+ Drug hits an enormous milestone as it enters a significant Safety Trial
...more
(9)
•••
averagepennies
X
Post by
averagepennies
on Feb 08, 2024 8:55am
Halberd and Mississippi State University to Commence Stage
JACKSON CENTER, PA / ACCESSWIRE / February 8, 2024 / Halberd Corporation's (OTC PINK:HALB) Traumatic Brain Injury (TBI) mitigating nasal spray testing protocols at Mississippi State
...more
(9)
•••
averagepennies
X
Post by
averagepennies
on Feb 06, 2024 8:46am
Halberd's Top Executives Join Forces with Athena GTX CEO Mar
JACKSON CENTER, PA / ACCESSWIRE / February 6, 2024 / Halberd Corporation's (OTC PINK:HALB) and Athena GTX's executives interviewed on "The Street Reports," discuss the
...more
(9)
•••
averagepennies
X
Post by
averagepennies
on Jan 11, 2024 8:13am
Halberd Corporation 2023 Year-End CEO Update and 2024 Goals
2023 ACHIEVEMENTS Halberd received from the CDC two sets of antibiotic resistant bacteria and fungi (a total of 60 samples) on which to test its proprietary laser eradication methodology. Testing
...more
(9)
•••
averagepennies
X
Post by
averagepennies
on Jan 09, 2024 9:38am
Halberd Corp. Signs Significant Revenue Sharing Agreement wi
Athena will employ its successful history of securing government contracts, spearheading such initiatives JACKSON CENTER, PA / ACCESSWIRE / January 9, 2024 / Halberd Corporation (OTC PINK
...more
(9)
•••
averagepennies
X
Post by
averagepennies
on Dec 13, 2023 8:13am
Halberd Corporation Signs Multi-Faceted Agreement with
Peter Croden, CrodenHealth Chairman, previously executive with Pharmacia & Upjohn (Pfizer), Upjohn Canada, Upjohn Global Animal Health, NephRx, and Parnell Pharmaceuticals Holdings, Ltd. Endeavors
...more
(9)
•••
averagepennies
X
Post by
averagepennies
on Nov 15, 2023 9:04am
Halberd Corporation Plans to Extend Research Partnership wit
JACKSON CENTER, PA / ACCESSWIRE / November 15, 2023 / Halberd Corporation (OTC PINK:HALB) is in talks with Mississippi State University (MSU) to extend its original six-month research arrangement
...more
(9)
•••
averagepennies
X
Post by
averagepennies
on Oct 10, 2023 8:26am
Hartman, CEO, and Dr. Felder, CTO of Halberd Corp, Featured
JACKSON CENTER, PA / ACCESSWIRE / October 10, 2023 / Halberd Corporation (OTC PINK:HALB) Chairman, President and CEO William A. Hartman and Chief Technology Officer, Dr Mitchell S
...more
(9)
•••
averagepennies
X
Post by
averagepennies
on Oct 04, 2023 10:07am
Halberd's Traumatic Brain Injury (TBI) Testing Results
JACKSON CENTER, PA / ACCESSWIRE / October 4, 2023 / Halberd Corporation's (OTC PINK:HALB) proprietary nasal spray testing results to mitigate the effects of Traumatic Brain Injury
...more
(9)
•••
averagepennies
X
Post by
averagepennies
on Sep 20, 2023 9:10am
Halberd and Athena GTX Collaborate on Advanced Traumatic
JACKSON CENTER, PA / ACCESSWIRE / September 20, 2023 / Halberd Corporation (OTC PINK:HALB) and Athena GTX, Inc, of Johnston, Iowa commenced collaboration on critical development of
...more
Prev
1
2
3
4
5
6
7
8
9
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Largest integrated facility services provider in Canada releases financial results for Q1, 2025
This company is set to benefit from a change in Ontario legislation
How Web3 Will Fundamentally Reshape Finance